Interviews on Esketamine, Depression and the Wish to have Children
A brief post on some interviews I gave recently on esketamine for treatment-resistant depression and depression in women who have problems getting pregnant.
FDA Approves Esketamine for Treatment-Resistant Depression, While US Suicide Rate Reaches Record High
/0 Comments/in Antidepressants, Depression, Psychopharmacology /by Gerhard GründerThe US FDA approved esketamine nasal spray on March 5th, 2019, while deaths from synthetic opioids and suicides hit a record high in 2017.
How Common are Withdrawal and Emotional Blunting in Chronic Antidepressant Treatment?
/0 Comments/in Antidepressants, Anxiety, Depression /by Gerhard GründerThe problem of withdrawal syndromes and emotional blunting occurring with prolonged antidepressant treatment is constantly underestimated by clinicians.
The Antidepressant Debate in the New York Times
/0 Comments/in Antidepressants, Depression, Withdrawal /by Gerhard GründerAn article on the front page of the New York Times on April 7, 2018, has fueled the debate over antidepressants again.
How effective are antidepressants?
/1 Comment/in Antidepressants, Metaanalysis, Psychopharmacology /by Gerhard GründerAndrea Cipriani from the University of Oxford and colleagues have recently published the largest and most comprehensive meta-analysis of the efficacy of antidepressants in the Lancet. The paper is worth dealing with more intensively.